САЩ - английски - NLM (National Library of Medicine)

pfizer manufacturing belgium nv - tozinameran (unii: 5085zfp6sj) (tozinameran - unii:5085zfp6sj), bnt162b2 omicron (ba.4/ba.5) (unii: jsv288q5cv) (bnt162b2 omicron (ba.4/ba.5) - unii:jsv288q5cv) -

Обединени арабски емирства - английски - MOHAP (Ministry of Health & Prevention) - وزارة الصحة ووقاية المجتمع.الإمارات

pfizer international corporation belgium - 195 multiple dose vials - injection - 30 µg/dose - n/a

Австралия - английски - Department of Health (Therapeutic Goods Administration)

pfizer australia pty ltd - daunorubicin hydrochloride, quantity: 20 mg (equivalent: daunorubicin, qty 18.7 mg) - injection, powder for - excipient ingredients: mannitol - pfizer daunorubicin powder for injection is indicated for the treatment of the following:,acute lymphocytic (lymphoblastic) leukaemia,daunorubicin is usually reserved for use in cases shown to be resistant to other drugs. however, combined treatment with daunorubicin, vincristine and a steroid has been used in the early stages of this disease.,acute myeloblastic leukaemia,daunorubicin has been used in all stages, alone or in combination with other cytotoxic agents (e.g., cytarabine).,disseminated solid tumours,daunorubicin has been investigated for use in these tumours and found to be effective in some cases of disseminated neuroblastoma and rhabdomyosarcoma.

Обединени арабски емирства - английски - MOHAP (Ministry of Health & Prevention) - وزارة الصحة ووقاية المجتمع.الإمارات

pfizer international corporation belgium - 195 multiple dose vials - injection - 30 µg/dose - n/a

Ирландия - английски - HPRA (Health Products Regulatory Authority)

pfizer healthcare ireland - deltamethrin - spot on solution - 1 %w/v - bovine - ectoparasiticide

Нова Зеландия - английски - Medsafe (Medicines Safety Authority)

pfizer new zealand limited - neisseria meningitidis group c polysaccharide 10ug (polysaccharide antigen from strain c11, conjugated to tetanus toxoid) - suspension for injection - 10 mcg/0.5ml - active: neisseria meningitidis group c polysaccharide 10ug (polysaccharide antigen from strain c11, conjugated to tetanus toxoid) excipient: aluminium hydroxide sodium chloride tetanus toxoid water for injection - active immunisation of children from 8 weeks of age, adolescents and adults for the prevention of invasive disease caused by neisseria meningitidis serogroup c.

Нова Зеландия - английски - Medsafe (Medicines Safety Authority)

pfizer new zealand limited - sildenafil citrate 140.45mg equivalent to 100 mg sildenafil - film coated tablet - 100 mg - active: sildenafil citrate 140.45mg equivalent to 100 mg sildenafil excipient: calcium hydrogen phosphate croscarmellose sodium magnesium stearate microcrystalline cellulose opadry blue oy-ls-20921 opadry clear ys-2-19114-a purified water - sildenafil pfizer is indicated for the treatment of erectile dysfunction in adult males.

Нова Зеландия - английски - Medsafe (Medicines Safety Authority)

pfizer new zealand limited - sildenafil citrate 35.112mg equivalent to 25 mg sildenafil - film coated tablet - 25 mg - active: sildenafil citrate 35.112mg equivalent to 25 mg sildenafil excipient: calcium hydrogen phosphate croscarmellose sodium magnesium stearate microcrystalline cellulose opadry blue oy-ls-20921 opadry clear ys-2-19114-a purified water - sildenafil pfizer is indicated for the treatment of erectile dysfunction in adult males.

Нова Зеландия - английски - Medsafe (Medicines Safety Authority)

pfizer new zealand limited - sildenafil citrate 70.225mg equivalent to 50 mg sildenafil - film coated tablet - 50 mg - active: sildenafil citrate 70.225mg equivalent to 50 mg sildenafil excipient: calcium hydrogen phosphate croscarmellose sodium magnesium stearate microcrystalline cellulose opadry blue oy-ls-20921 opadry clear ys-2-19114-a purified water - sildenafil pfizer is indicated for the treatment of erectile dysfunction in adult males.

Европейски съюз - английски - myHealthbox

pfizer limited - crizotinib - hard capsules - 200 mg - carcinoma, non-small-cell lung - anti-neoplastic agents, protein kinase inhibitor - indicated for the treatment of adults with previously treated anaplastic lymphoma kinase (alk)-positive advanced non-small cell lung cancer (nsclc)